Загрузка...
Rituximab therapy for primary glomerulonephritis: Report on two cases
The evidence in the medical literature on the efficacy and safety of rituximab therapy for primary glomerulonephritis is limited and controversial. We describe two male Caucasian patients with rapidly progressive kidney failure due to primary proliferative glomerulonephritis. Both of them received h...
Сохранить в:
| Опубликовано в: : | World J Clin Cases |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539414/ https://ncbi.nlm.nih.gov/pubmed/26301235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v3.i8.736 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|